Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Prestige Consumer Healthcare (PBH) Shares Outstanding (2016 - 2025)

Prestige Consumer Healthcare has reported Shares Outstanding over the past 16 years, most recently at $56.2 million for Q4 2025.

  • For Q4 2025, Shares Outstanding changed 0.46% year-over-year to $56.2 million; the TTM value through Dec 2025 reached $56.2 million, changed 0.46%, while the annual FY2025 figure was $56.0 million, 0.92% up from the prior year.
  • Shares Outstanding for Q4 2025 was $56.2 million at Prestige Consumer Healthcare, roughly flat from $56.2 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $56.2 million in Q4 2025 and troughed at $54.0 million in Q1 2021.
  • A 5-year average of $55.2 million and a median of $55.3 million in 2023 define the central range for Shares Outstanding.
  • Biggest five-year swings in Shares Outstanding: grew 0.36% in 2021 and later increased 1.17% in 2024.
  • Year by year, Shares Outstanding stood at $54.4 million in 2021, then increased by 0.92% to $54.9 million in 2022, then increased by 0.87% to $55.3 million in 2023, then grew by 1.1% to $55.9 million in 2024, then rose by 0.46% to $56.2 million in 2025.
  • Business Quant data shows Shares Outstanding for PBH at $56.2 million in Q4 2025, $56.2 million in Q3 2025, and $56.2 million in Q2 2025.